Wolverine Trading, LLC Novo Nordisk A S Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wolverine Trading, LLC holds 19,179 shares of NVO stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,179
Previous 75,053 74.45%
Holding current value
$1.97 Million
Previous $10.7 Million 78.69%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $6.65 Million - $8.13 Million
-55,874 Reduced 74.45%
19,179 $2.28 Million
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $4.39 Million - $5.25 Million
35,754 Added 90.98%
75,053 $10.7 Million
Q1 2024

May 15, 2024
BUY
$102.11 - $135.92 $2.49 Million - $3.31 Million
24,384 Added 163.49%
39,299 $5.05 Million
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $146,417 - $175,890
1,668 Added 12.59%
14,915 $1.54 Million
Q3 2023

Nov 15, 2023
BUY
$90.94 - $199.54 $607,115 - $1.33 Million
6,676 Added 101.6%
13,247 $1.2 Million
Q2 2023

Aug 23, 2023
BUY
$155.98 - $172.65 $378,875 - $419,366
2,429 Added 58.64%
6,571 $1.06 Million
Q1 2023

May 15, 2023
SELL
$132.34 - $159.14 $1.02 Million - $1.23 Million
-7,725 Reduced 65.1%
4,142 $655,000
Q4 2022

Feb 14, 2023
BUY
$102.55 - $135.33 $923,360 - $1.22 Million
9,004 Added 314.5%
11,867 $1.61 Million
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $272,786 - $334,770
2,863 New
2,863 $287,000
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $591,771 - $722,617
-6,172 Reduced 74.65%
2,096 $234,000
Q2 2021

Aug 06, 2021
BUY
$67.66 - $84.76 $559,412 - $700,795
8,268 New
8,268 $693,000
Q1 2020

May 11, 2020
SELL
$49.46 - $64.78 $278,113 - $364,257
-5,623 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
$49.86 - $58.26 $292,728 - $342,044
-5,871 Reduced 51.08%
5,623 $325,000
Q3 2019

Nov 14, 2019
BUY
$47.54 - $53.43 $153,982 - $173,059
3,239 Added 39.24%
11,494 $593,000
Q2 2019

Aug 20, 2019
BUY
$46.79 - $52.47 $99,148 - $111,183
2,119 Added 34.53%
8,255 $421,000
Q1 2019

May 15, 2019
SELL
$46.36 - $52.63 $641,390 - $728,136
-13,835 Reduced 69.28%
6,136 $321,000
Q4 2018

Feb 14, 2019
BUY
$41.54 - $47.25 $268,473 - $305,376
6,463 Added 47.85%
19,971 $915,000
Q3 2018

Nov 14, 2018
BUY
$46.76 - $51.24 $43,019 - $47,140
920 Added 7.31%
13,508 $637,000
Q1 2018

May 15, 2018
BUY
$48.49 - $58.14 $610,392 - $731,866
12,588 New
12,588 $620,000
Q4 2017

Feb 14, 2018
SELL
$47.53 - $53.73 $414,271 - $468,310
-8,716 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$41.15 - $49.22 $358,663 - $429,001
8,716
8,716 $420,000

Others Institutions Holding NVO

# of Institutions
1,952
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email